Covalis Capital’s Alto Ingredients ALTO Stock Holding History

Covalis Capital’s Portfolio ALTO Stock Details ALTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-727,357	Closed	-$3.95M	–	128
2021 Q1	$3.95M	Buy	+727,357	New	+$4.81M	0.81%	32

Other funds holding ALTO

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covalis Capital's ALTO Position: Q2 2021 in Review

Covalis Capital sold out of Alto Ingredients (ALTO) in Q2 2021, closing a stake of 727,357 shares — an estimated $3.95M sold.

Covalis Capital first reported a position in ALTO in Q1 2021 and held it in 1 quarter. The position peaked at $3.95M in Q1 2021. 122 funds tracked by Wall St. Rank hold ALTO as of Q2 2021.

Covalis Capital reported no remaining Alto Ingredients position as of Q2 2021 after selling out during the quarter.
Covalis Capital sold 727,357 Alto Ingredients shares in Q2 2021, an estimated $3.95M.
Covalis Capital first reported a position in Alto Ingredients in Q1 2021 and held it in 1 quarter.
Covalis Capital's Alto Ingredients position peaked at $3.95M in Q1 2021.
122 funds tracked by Wall St. Rank held Alto Ingredients as of Q2 2021.

Based on Covalis Capital's 13F filing for Q2 2021, filed 16 Aug 2021.